GlassScriptPhysician profile
Philip K Wiles
NPI 1275651077
$2,432.14
in general payments reported to CMS, 2019-2025
32 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $295 · 2021: $483 · 2022: $250 · 2023: $721 · 2024: $352 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,204.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $480.19 | 2019-2024 | Da Vinci Surgical System |
| Integra Lifesciences Corporation | $314.85 | 2021-2024 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Davol INC. | $239.73 | 2020-2023 | Phasix Mesh |
| Tela Bio, INC. | $200.08 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Conmed Corporation | $174.21 | 2021-2023 | Airseal |
| Kerecis Limited | $164.93 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Polynovo North America LLC | $82.87 | 2022-2023 | |
| Smith+Nephew, INC. | $79.20 | 2021-2022 | |
| La Jolla Pharmaceutical Company | $71.80 | 2023-2024 | Xerava |
| Acell, INC. | $64.68 | 2019-2020 | |
| Molli Surgical (US) INC | $61.03 | 2023 | |
| Merit Medical Systems INC | $47.95 | 2023-2025 | Savi Scout |
| Solventum Corporation | $46.30 | 2025 | V.A.C. Veraflo, Prevena, Activ.A.C. |
| Dilon Technologies, INC. | $37.11 | 2021-2024 | Hemoblast Bellows |
| Bk Medical Holding Company INC. | $32.95 | 2024 | Bk3000, Bk3500 & Bk5000 Ultrasound System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $31.79 | 2022-2025 | Perclot |
| Intra-Sana Laboratories | $31.28 | 2021 | |
| Merck Sharp & Dohme LLC | $30.64 | 2024 | Lynparza, Keytruda |
| Zyla Life Sciences, INC. | $29.97 | 2019 | |
| Organogenesis INC. | $23.74 | 2025 | Puraply Wound Matrix |
| Ascensia Diabetes Care US INC. | $19.84 | 2023 | |
| Bard Peripheral Vascular, INC. | $19.42 | 2021 | |
| Convatec INC. | $18.15 | 2022 | |
| Medtronic, INC. | $17.05 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.64 | 2022 | |
| Kci USA, INC. | $16.28 | 2021 | |
| Endogastric Solutions, INC | $15.03 | 2022 | |
| Innocoll Pharmaceuticals Limited | $14.81 | 2021 | |
| Bioptics, INC. | $14.23 | 2019 | |
| Ethicon US, LLC | $12.68 | 2020 | |
| Abbott Laboratories | $12.25 | 2019 | |
| Reshape Lifesciences INC. | $10.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Wiles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.